379 related articles for article (PubMed ID: 21480863)
21. Retinal images benchmark for the detection of diabetic retinopathy and clinically significant macular edema (CSME).
Noor-Ul-Huda M; Tehsin S; Ahmed S; Niazi FAK; Murtaza Z
Biomed Tech (Berl); 2019 May; 64(3):297-307. PubMed ID: 30055096
[TBL] [Abstract][Full Text] [Related]
22. Role of advanced glycation end products (AGEs) and oxidative stress in diabetic retinopathy.
Yamagishi S; Ueda S; Matsui T; Nakamura K; Okuda S
Curr Pharm Des; 2008; 14(10):962-8. PubMed ID: 18473846
[TBL] [Abstract][Full Text] [Related]
23. The peroxisome proliferator-activated receptor-β/δ antagonist GSK0660 mitigates retinal cell inflammation and leukostasis.
Capozzi ME; Savage SR; McCollum GW; Hammer SS; Ramos CJ; Yang R; Bretz CA; Penn JS
Exp Eye Res; 2020 Jan; 190():107885. PubMed ID: 31758977
[TBL] [Abstract][Full Text] [Related]
24. Association between
Li XF; Jiang GB; Cheng SY; Song YF; Deng C; Niu YM; Cai JW
Aging (Albany NY); 2021 Feb; 13(4):5136-5149. PubMed ID: 33535175
[TBL] [Abstract][Full Text] [Related]
25. Diabetic retinopathy--biomolecules and multiple pathophysiology.
Ahsan H
Diabetes Metab Syndr; 2015; 9(1):51-4. PubMed ID: 25450817
[TBL] [Abstract][Full Text] [Related]
26. Diabetic Retinopathy: Pathophysiology and Treatments.
Wang W; Lo ACY
Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29925789
[TBL] [Abstract][Full Text] [Related]
27. Alpha-1-antitrypsin ameliorates inflammation and neurodegeneration in the diabetic mouse retina.
Ortiz G; Lopez ES; Salica JP; Potilinski C; Fernández Acquier M; Chuluyan E; Gallo JE
Exp Eye Res; 2018 Sep; 174():29-39. PubMed ID: 29778740
[TBL] [Abstract][Full Text] [Related]
28. Improvement in Diabetic Retinopathy through Protection against Retinal Apoptosis in Spontaneously Diabetic Torii Rats Mediated by Ethanol Extract of
Kim CS; Kim J; Kim YS; Jo K; Lee YM; Jung DH; Lee IS; Kim JH; Kim JS
Nutrients; 2019 Mar; 11(3):. PubMed ID: 30836664
[TBL] [Abstract][Full Text] [Related]
29. Nutraceuticals for the Treatment of Diabetic Retinopathy.
Rossino MG; Casini G
Nutrients; 2019 Apr; 11(4):. PubMed ID: 30987058
[TBL] [Abstract][Full Text] [Related]
30. Resveratrol exhibits an effect on attenuating retina inflammatory condition and damage of diabetic retinopathy via PON1.
Chen Y; Meng J; Li H; Wei H; Bi F; Liu S; Tang K; Guo H; Liu W
Exp Eye Res; 2019 Apr; 181():356-366. PubMed ID: 30503749
[TBL] [Abstract][Full Text] [Related]
31. Treatment of diabetic retinopathy through neuropeptide Y-mediated enhancement of neurovascular microenvironment.
Ou K; Copland DA; Theodoropoulou S; Mertsch S; Li Y; Liu J; Schrader S; Liu L; Dick AD
J Cell Mol Med; 2020 Apr; 24(7):3958-3970. PubMed ID: 32141716
[TBL] [Abstract][Full Text] [Related]
32. Diabetic retinopathy.
Wong TY; Cheung CM; Larsen M; Sharma S; Simó R
Nat Rev Dis Primers; 2016 Mar; 2():16012. PubMed ID: 27159554
[TBL] [Abstract][Full Text] [Related]
33. Effect of berberine on PPARalpha/delta/gamma expression in type 2 diabetic rat retinae.
Zhou JY; Zhou SW
Yao Xue Xue Bao; 2007 Dec; 42(12):1243-9. PubMed ID: 18338635
[TBL] [Abstract][Full Text] [Related]
34. Chinese Medicines in Diabetic Retinopathy Therapies.
Song W; Zhu YW
Chin J Integr Med; 2019 Apr; 25(4):316-320. PubMed ID: 30264267
[TBL] [Abstract][Full Text] [Related]
35. Implications of the endogenous PPAR-gamma ligand, 15-deoxy-delta-12, 14-prostaglandin J2, in diabetic retinopathy.
Behl T; Kaur I; Goel H; Kotwani A
Life Sci; 2016 May; 153():93-9. PubMed ID: 27060220
[TBL] [Abstract][Full Text] [Related]
36. SGLT2 Inhibitor-Induced Low-Grade Ketonemia Ameliorates Retinal Hypoxia in Diabetic Retinopathy-A Novel Hypothesis.
Mudaliar S; Hupfeld C; Chao DL
J Clin Endocrinol Metab; 2021 Apr; 106(5):1235-1244. PubMed ID: 33512450
[TBL] [Abstract][Full Text] [Related]
37. Successful Midterm Management With an Herbal Decoction, Modified-Goshajinkigan (mGJG) for Non-Proliferative Diabetic Retinopathy: A Case Study.
Kim J; Moon E; Kim TH
Explore (NY); 2018; 14(4):295-299. PubMed ID: 29793732
[TBL] [Abstract][Full Text] [Related]
38. [Angiopathy and the eye].
Rencová E
Vnitr Lek; 2010 Apr; 56(4):333-9. PubMed ID: 20465107
[TBL] [Abstract][Full Text] [Related]
39. Suppression of retinal peroxisome proliferator-activated receptor gamma in experimental diabetes and oxygen-induced retinopathy: role of NADPH oxidase.
Tawfik A; Sanders T; Kahook K; Akeel S; Elmarakby A; Al-Shabrawey M
Invest Ophthalmol Vis Sci; 2009 Feb; 50(2):878-84. PubMed ID: 18806296
[TBL] [Abstract][Full Text] [Related]
40. Angiogenic and antiangiogenic factors in proliferative diabetic retinopathy.
Simó R; Carrasco E; García-Ramírez M; Hernández C
Curr Diabetes Rev; 2006 Feb; 2(1):71-98. PubMed ID: 18220619
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
